Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management.

Publication date: Sep 01, 2024

Coronavirus disease 2019 (COVID-19) was first identified in December 2019 and quickly became a global pandemic. The understanding of the pathophysiology, treatment, and management of the disease has evolved since the beginning of the pandemic in 2020. COVID-19 can be complicated by immune system dysfunction, lung injury with hypoxemia, acute kidney injury, and coagulopathy. The treatment and management of COVID-19 is based on the severity of illness, ranging from asymptomatic to severe and often life-threatening disease. The 3 main recommended medication classes include antivirals, immunomodulators, and anticoagulants. Other supportive therapies include ensuring adequate oxygenation, mechanical ventilation, and prone positioning.

Concepts Keywords
Classes Adult
Coronavirus Antiviral Agents
December Antiviral Agents
Kidney Coronavirus
Nursing COVID-19
COVID-19
Critical Care Nursing
Evidenced-based practice
Humans
Pathophysiology
SARS-CoV-2
SARS-CoV-2

Semantics

Type Source Name
disease MESH Coronavirus Disease 2019
pathway REACTOME Immune System
disease MESH lung injury
disease MESH acute kidney injury

Original Article

(Visited 1 times, 1 visits today)